Syndax Pharmaceuticals Inc. Revenue 2015–2025
Syndax Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Syndax Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 64.9 M, a 223.64% increase year-over-year.
- Syndax Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 168.7 M, a 954.59% increase year-over-year.
- Syndax Pharmaceuticals Inc. annual revenue for 2025 was 172.4 M, a 627.84% increase from 2024.
- Syndax Pharmaceuticals Inc. annual revenue for 2024 was 23.7 M.
- Syndax Pharmaceuticals Inc. annual revenue for 2023 was 0.
- Syndax Pharmaceuticals Inc. annual revenue for 2022 was 0.
Syndax Pharmaceuticals Inc. (SNDX) — Frequently Asked Questions
Syndax Pharmaceuticals Inc. (SNDX) is a publicly traded US company. It has a market capitalization of $1.52B. In fiscal 2025 it reported revenue of $172M and net income of -$285M. Explore SNDX's stock price, financial statements, earnings history, margins and key ratios below.
What is Syndax Pharmaceuticals Inc.'s market cap?
Syndax Pharmaceuticals Inc. (SNDX) has a market capitalization of $1.52B.
What is the SNDX stock price?
SNDX trades at $17.58 (-0.62% on the day).
How much revenue does Syndax Pharmaceuticals Inc. make?
Syndax Pharmaceuticals Inc. reported revenue of $172M in fiscal 2025.
Is SNDX profitable?
In fiscal 2025, Syndax Pharmaceuticals Inc. reported net income of -$285M.